ASCP's 40 Under Forty Program Recognizes Future Generation of Laboratory Leaders
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: PR Web
CHICAGO (PRWEB) July 31, 2018 The American Society for Clinical Pathology (ASCP) is recognizing 40 members under the age of 40 for their achievements and leadership qualities that are making an impact on pathology and laboratory medicine. This year's ASCP 40 Under Forty honorees join 160 alumni of this prestigious recognition program. And like these alums, they will continue to advance into even more prominent positions and accomplishments in the coming years.From this group, the Top Five 40 Under Forty honorees were selected based on public voting and committee selection. Each of the five will receive free registration to attend the ASCP 2018 Annual Meeting, Oct. 3-5, in Baltimore, a $1,000 stipend toward airfare and lodging, and recognition at the Annual Meeting. Here is a look at this year's Top Five honorees:Jordan Baum, MD, is a molecular genetic pathology fellow at New York Presbyterian Hospital-Weill Cornell, New York, NY, and plans to pursue a career in academic medicine with
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Closed System Transfer Devices Market Size Expected to Reach USD 5.39 Bn by 2033 | Expansion of Oncology and Infusion Services [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA [Yahoo! Finance]Yahoo! Finance
- Becton, Dickinson and Company (NYSE: BDX) had its price target raised by analysts at Barclays PLC from $305.00 to $312.00. They now have an "overweight" rating on the stock.MarketBeat
- Injectable Drug Delivery Market Worth $1139.4 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 5/2/24 - Beat
BDX
Sec Filings
- 5/10/24 - Form SD
- 5/6/24 - Form 4
- 5/6/24 - Form 4
- BDX's page on the SEC website